BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//REMEDi4ALL - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://remedi4all.org
X-WR-CALDESC:Events for REMEDi4ALL
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20230312T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20231105T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20240310T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20241103T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240508T090000
DTEND;TZID=America/Halifax:20240508T143000
DTSTAMP:20260422T021122
CREATED:20240319T091036Z
LAST-MODIFIED:20240319T091036Z
UID:5904-1715158800-1715178600@remedi4all.org
SUMMARY:Clinical Pharmacology Guidances Advancing Drug Development and Regulatory Assessment
DESCRIPTION:ABOUT THIS EVENT\nThis public workshop will be hosted by the FDA Office of Clinical Pharmacology (OCP) and the University of Maryland Center of Excellence in Regulatory Science and Innovation (M-CERSI). The purpose of this workshop is to serve as a mechanism to engage with the public to share information on existing clinical pharmacology guidances and identify emerging scientific topics that might benefit from the development of scientific research and recommendations. \nBACKGROUND\nAt every step of drug development\, clinical pharmacology is applied to generate\, evaluate\, and use knowledge of drug disposition\, pharmacology\, and disease biology to progressively reduce regulatory uncertainty and inform public health decision-making.   Clinical pharmacology principles form the basis of dosage selection and optimisation and promote therapeutic individualisation by translating the knowledge of patient diversity into clinical recommendations for safe and effective use of medications.   Therefore\, having clear\, pragmatic\, and contemporary scientific recommendations to inform drug development and regulatory assessment is critical for the successful and efficient development of therapeutics that protect and promote public health. Developing new or revising existing guidance documents\, especially in the broad field of clinical pharmacology\, requires a unique and integrated approach centered around multistakeholder partnerships. \nWORKSHOP GOALS\n\n\nProvide an overview of scientific recommendations pertaining to clinical pharmacology applications during drug development and regulatory assessment. \n\n\nDiscuss the current scientific challenges and gaps in applying clinical pharmacology principles during drug development. \n\n\nIdentify potential opportunities and priorities for regulatory research and scientific guidance development from a clinical pharmacology perspective. \n\n\nAGENDA\nClick here to see the full agenda. \nREGISTRATION\nRegistration is free.  All interested parties are encouraged to register early. Please click here to register. \n\nClick here to learn more.
URL:https://remedi4all.org/event/clinical-pharmacology-guidances-advancing-drug-development-and-regulatory-assessment/
LOCATION:Online & in-person (Maryland\, United States)\, MD\, United States
ATTACH;FMTTYPE=image/png:https://remedi4all.org/wp-content/uploads/2024/03/Event-Page-Image-R4A-169-ratio.png
END:VEVENT
END:VCALENDAR